Elham Hershberger

Insider Reports History

Location
Waltham, MA
Signature
/s/ Jane Pritchett Henderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elham Hershberger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adagio Therapeutics, Inc. Chief Development Officer Common Stock 127,060 $501,887 $3.95 05 Aug 2021 Direct
Adagio Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 175,000 30 Jan 2022 Direct

Insider Reports Filed by Elham Hershberger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IVVD Adagio Therapeutics, Inc. 30 Jan 2022 1 $0 4 Chief Development Officer 01 Feb 2022, 17:18
IVVD Adagio Therapeutics, Inc. 05 Aug 2021 0 $0 3 Chief Development Officer 05 Aug 2021, 21:21